相关实验视频
Updated: Jun 15, 2025

06:21
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
53
晚间尿动频率与日本性结肠炎患者的临床结果之间的关联
Shogo Kitahata1, Shinya Furukawa2, Teruki Miyake3
1Department of Gastroenterology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan.
Neurourology and urodynamics
|August 23, 2024
概括
夜间尿动频率与性结肠炎 (UC) 患者的较差结果有关. 增加的夜间空洞可能表明粘膜愈合程度较低,这表明它可能是UC管理的有用临床信号.
科学领域:
- 胃肠病学 胃肠病学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 临床医学 临床医学
背景情况:
- 夜尿,下泌尿道综合征 (LUTS) 的常见症状,经常在性结肠炎 (UC) 患者中观察到.
- 虽然LUTS和结直肠炎症之间存在关联,但UC患者夜间尿动频率的具体数据有限.
- 这项研究通过调查夜间尿动频率与UC的临床结果之间的关系来弥补这一差距.
研究的目的:
- 检查夜间尿动频率与日本性结肠炎 (UC) 患者的临床结果之间的关联.
- 确定夜间尿动频率是否与UC患者的粘膜愈合 (MH) 和临床缓解 (CR) 相相关.
主要方法:
- 一项针对287名日本UC患者的调查,使用自我管理的问卷.
- 根据夜间尿动频率,患者被分为三组:没有空洞,一个空洞,两个或更多的空洞.
- 使用多变量逻辑回归分析来评估夜间尿动频率与MH和CR的患病率之间的关联.
主要成果:
- 35.5%的患者经历了一次夜间空虚,而26.8%的患者经历了两次或更多.
- 粘膜愈合 (MH) 和临床缓解 (CR) 率分别为24.7%和59.2%.
- 两个或两个以上的夜间空洞独立地和反向地与MH相关 (调整后OR:0.31). 这种关联在非老年患者和CR患者中仍然显著.
结论:
- 夜间尿动频率与日本UC患者的粘膜愈合相反.
- 增加夜间尿动频率可以作为评估UC的粘膜愈合的补充临床指标.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
159
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
159
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
329
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
329
Drugs for Treatment of Ulcerative Colitis in IBD
130
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
130

